Help keep the good days coming1,2
The first & only approved treatment to help cats gain and maintain weight long term1 *.
Eluracat™, your new cornerstone to support cats with chronic medical
conditions, helping them gain and maintain weight1.
Mimics ghrelin, the endogenous hunger hormone3
Dual action increases food intake & weight gain1
Oral solution suitable for long-term use1 *
Once daily liquid with vanilla flavouring with low dosing volume
Tackling weight loss early
Nearly 1 in 5 cats seen in veterinary consultations are affected by unintended weight loss.4 It can be an early indicator of chronic diseases like chronic kidney disease (CKD), cancer, hyperthyroidism, chronic gastrointestinal disease and congestive heart failure.5,6
If unintended weight loss is not addressed, there can be gradual but significant effects on strength, immune function, wound healing, quality of life and survival time of cats5. Weight loss is also distressing for owners and is a major contributing factor to a decision of euthanasia as pet owners may perceive changes in appetite as evidence of suffering2.
Eluracat™ can be prescribed at the first sign of weight loss.
Eluracat™ restores a cat's normal ability to gain and maintain weight3,7
In a randomized placebo controlled pivotal field study, 8 out of 10 cats prescribed Eluracat™ gained weight throughout the duration of the study.3
Cats given Eluracat gained significantly more weight (3.3%) vs controls in the first 15 days.
Cats treated with Eluracat showed 6.8% eight increases vs controls by day 55.
Cats without treatment continued to lose weight over the period.
56-day study in 176 cats with mean age of 15 years and ≥5% unintended weight loss at enrolment.
Eluracat™ is indicated for body weight gain in cats experiencing poor appetite or unintended weight loss resulting from chronic medical conditions
IRIS guidelines recommend capromorelin for the treatment of weight loss in cats with CKD8**.
How Eluracat™ works
Capromorelin is the only selective ghrelin receptor agnoist approved in veterinary medicine. Eluracat's dual action increases food intake and weight gain1.
Suitable for long term use, Eluracat is well tolerated in cats with CKD & other chronic conditions1,3*
Eluracat™ has been used alongside other common medications for CKD & chronic conditions1,9***
The most common side effect seen with Eluracat™ is mild hypersalivation which resolves within minutes of initial dosing1.
No negative effect on efficacy as weight still increased by an average of 6% in cases with hypersalivation3
Eluracat™, a unique solution to help you manage weight loss in chronic conditions such as CKD
In cats with CKD, weight loss is common and ranges from 42% to 82%2. Additionally, these cats may experience anemia, vomiting, nausea, proteinuria and other conditions that cause pain.
Managing chronic kidney disease in cats often requires a holistic approach. See how Elanco can help with our solutions for cats with CKD:
- Eluracat Summary of Product Characteristics
- Freeman LM et al. J Vet Intern Med 2016;30:1661-66
- Wofford JA et al.J Fel Med Surg 2025;27:1098612X251379924
- Elanco study: Elura quantitative pricing 2023
- Freeman, L.M. J Vet Intern Med 2012, pp. 3–17
- Peterson ME et al. J Vet Intern Med. 2016 Nov;30(6):1780-1789.
- Brusach K et al. Vet Sci 2023;10:464
- IRIS Treatment Recommendations for CKD in Cats 2023. https://www.iris-kidney.com/iris-guidelines-1. Accessed March 2026.
- Elanco study AT-002-FCL-16-004
* As safety evaluations were limited to 90 days, use beyond this should be based on a risk:benefit analysis by the prescribing vet1
** for the treatment of weight loss in cats with stage 2 and above CKD8
*** Please refer to SPC section 3.8 for more information
